Ashton Thomas Private Wealth’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $945K | Sell |
2,122
-220
| -9% | -$97.9K | 0.03% | 427 |
|
|
2025
Q1 | $1.14M | Buy |
2,342
+255
| +12% | +$124K | 0.04% | 356 |
|
|
2024
Q4 | $840K | Sell |
2,087
-204
| -9% | -$82.2K | 0.03% | 415 |
|
|
2024
Q3 | $1.07M | Sell |
2,291
-48
| -2% | -$22.3K | 0.06% | 301 |
|
|
2024
Q2 | $1.1M | Buy |
2,339
+93
| +4% | +$43.6K | 0.06% | 291 |
|
|
2024
Q1 | $939K | Buy |
2,246
+300
| +15% | +$125K | 0.05% | 309 |
|
|
2023
Q4 | $792K | Buy |
1,946
+1,043
| +116% | +$424K | 0.05% | 335 |
|
|
2023
Q3 | $314K | Buy |
903
+11
| +1% | +$3.83K | 0.02% | 469 |
|
|
2023
Q2 | $314K | Buy |
892
+24
| +3% | +$8.45K | 0.02% | 472 |
|
|
2023
Q1 | $273K | Sell |
868
-61
| -7% | -$19.2K | 0.02% | 431 |
|
|
2022
Q4 | $268K | Buy |
929
+56
| +6% | +$16.2K | 0.03% | 414 |
|
|
2022
Q3 | $253K | Sell |
873
-71
| -8% | -$20.6K | 0.03% | 410 |
|
|
2022
Q2 | $266K | Buy |
944
+55
| +6% | +$15.5K | 0.03% | 396 |
|
|
2022
Q1 | $232K | Buy |
+889
| New | +$232K | 0.02% | 441 |
|